167 related articles for article (PubMed ID: 28623316)
1. Revealing protein networks and gene-drug connectivity in cancer from direct information.
Jiang XL; Martinez-Ledesma E; Morcos F
Sci Rep; 2017 Jun; 7(1):3739. PubMed ID: 28623316
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive expression-based isoform biomarkers predictive of drug responses based on isoform co-expression networks and clinical data.
Ma J; Wang J; Ghoraie LS; Men X; Chen R; Dai P
Genomics; 2020 Jan; 112(1):647-658. PubMed ID: 31029864
[TBL] [Abstract][Full Text] [Related]
3. PharmGKB summary: sorafenib pathways.
Gong L; Giacomini MM; Giacomini C; Maitland ML; Altman RB; Klein TE
Pharmacogenet Genomics; 2017 Jun; 27(6):240-246. PubMed ID: 28362716
[No Abstract] [Full Text] [Related]
4. Introduction: Cancer Gene Networks.
Clarke R
Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
[TBL] [Abstract][Full Text] [Related]
5. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
6. Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs.
Li J; Lei K; Wu Z; Li W; Liu G; Liu J; Cheng F; Tang Y
Oncotarget; 2016 Jul; 7(29):45584-45596. PubMed ID: 27329603
[TBL] [Abstract][Full Text] [Related]
7. Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies.
Geeleher P; Zhang Z; Wang F; Gruener RF; Nath A; Morrison G; Bhutra S; Grossman RL; Huang RS
Genome Res; 2017 Oct; 27(10):1743-1751. PubMed ID: 28847918
[TBL] [Abstract][Full Text] [Related]
8. Contextualization of drug-mediator relations using evidence networks.
Tran HJ; Speyer G; Kiefer J; Kim S
BMC Bioinformatics; 2017 May; 18(Suppl 7):252. PubMed ID: 28617226
[TBL] [Abstract][Full Text] [Related]
9. ccmGDB: a database for cancer cell metabolism genes.
Kim P; Cheng F; Zhao J; Zhao Z
Nucleic Acids Res; 2016 Jan; 44(D1):D959-68. PubMed ID: 26519468
[TBL] [Abstract][Full Text] [Related]
10. A network flow-based method to predict anticancer drug sensitivity.
Qin Y; Chen M; Wang H; Zheng X
PLoS One; 2015; 10(5):e0127380. PubMed ID: 25992881
[TBL] [Abstract][Full Text] [Related]
11. Network-Oriented Approaches to Anticancer Drug Response.
Lecca P; Re A
Methods Mol Biol; 2017; 1513():101-117. PubMed ID: 27807833
[TBL] [Abstract][Full Text] [Related]
12. [Construction and analysis of a breast cancer gene-drug network model].
Wei X; Hu DH; Yi MH; Chang XL; Zhu WJ; Qu SL; Deng DY
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):170-9. PubMed ID: 26922011
[TBL] [Abstract][Full Text] [Related]
13. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles.
Li X; Xu Y; Cui H; Huang T; Wang D; Lian B; Li W; Qin G; Chen L; Xie L
Artif Intell Med; 2017 Nov; 83():35-43. PubMed ID: 28583437
[TBL] [Abstract][Full Text] [Related]
14. Cancer network activity associated with therapeutic response and synergism.
Serra-Musach J; Mateo F; Capdevila-Busquets E; de Garibay GR; Zhang X; Guha R; Thomas CJ; Grueso J; Villanueva A; Jaeger S; Heyn H; Vizoso M; Pérez H; Cordero A; Gonzalez-Suarez E; Esteller M; Moreno-Bueno G; Tjärnberg A; Lázaro C; Serra V; Arribas J; Benson M; Gustafsson M; Ferrer M; Aloy P; Pujana MÀ
Genome Med; 2016 Aug; 8(1):88. PubMed ID: 27553366
[TBL] [Abstract][Full Text] [Related]
15. Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer.
Ivliev AE; 't Hoen PA; Borisevich D; Nikolsky Y; Sergeeva MG
PLoS One; 2016; 11(11):e0165059. PubMed ID: 27824868
[TBL] [Abstract][Full Text] [Related]
16. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
17. Oncoproteomics.
Joshi S; Tiwari AK; Mondal B; Sharma A
Clin Chim Acta; 2011 Jan; 412(3-4):217-26. PubMed ID: 20955692
[TBL] [Abstract][Full Text] [Related]
18. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
Wang L; Li X; Zhang L; Gao Q
BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
[TBL] [Abstract][Full Text] [Related]
19. DMirNet: Inferring direct microRNA-mRNA association networks.
Lee M; Lee H
BMC Syst Biol; 2016 Dec; 10(Suppl 5):125. PubMed ID: 28105958
[TBL] [Abstract][Full Text] [Related]
20. [Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers].
Nishiyama M
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1902-7. PubMed ID: 16282724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
